Day: January 7, 2025
OKLAHOMA CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced it will report fourth-quarter and full-year 2024 results on Tuesday, Feb. 18, after the close of U.S. financial markets. The earnings release and presentation for the fourth-quarter 2024 results will be available on the company’s website at www.devonenergy.com.
On Wednesday, Feb. 19, the company will hold a conference call at 10 a.m. CST (11 a.m. EST), which will consist primarily of answers to questions from analysts and investors. A webcast link to the conference call will be provided on Devon’s website at www.devonenergy.com. A replay will be available on the website following the call.
ABOUT DEVON ENERGY
Devon Energy is a leading oil and gas producer in the U.S. with a premier multi-basin portfolio headlined by a world-class acreage...
GCC Announces Q4 2024 Conference Call Details
Written by Customer Service on . Posted in Public Companies.
CHIHUAHUA, Mexico, Jan. 07, 2025 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, will host a conference call to review its fourth quarter 2024 earnings results on Wednesday, January 29 at 10:00 a.m. (ET). Earnings results for the quarter ended December 31, 2024, will be released on Tuesday, January 28, after market close.
The call will be hosted by Enrique Escalante, CEO, and Maik Strecker, CFO, and can be accessed by dialing +1 (877) 407 0789 or +1 (201) 689 8562 for international calls. The conference ID is 13750646.
The presentation and listen-only webcast will be available via the following link.
A replay of the webcast will be available the same day at 2:00 p.m. (ET) until February 5 at 11:59 p.m. (ET). The replay can be accessed through this link...
Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change
Written by Customer Service on . Posted in Public Companies.
Addison, TX, Jan. 07, 2025 (GLOBE NEWSWIRE) — PatentVest, a leader in intellectual property (IP) intelligence and strategy, has released its latest report, “Continuous Glucose Monitoring (CGM): An Evolving Innovation Landscape.” This in-depth analysis explores the rapidly growing CGM market, offering valuable insights into the trends, key players, and opportunities that are shaping the future of diabetes care.
Diabetes is one of the most pressing global health challenges, affecting an estimated 537 million adults worldwide in 2021—a number projected to rise to 783 million by 2045. As the complexity of diabetes management grows, the need for continuous, real-time glucose monitoring has never been more critical. Continuous Glucose Monitors (CGMs) address these challenges by providing patients with timely insights into their glucose...
Kaldvik AS: Resignation of board member
Written by Customer Service on . Posted in Public Companies.
Reykjavík, 7 January 2025: Aðalsteinn Ingólfsson has today notified the board of directors that he resigns as board member of Kaldvik AS. Mr. Ingólfsson has been a member of the board of directors since September 2022. His resignation has been accepted and is effective immediately.
On behalf of the company, the board of directors extends its gratitude to Aðalsteinn for his service and contributions over the past years.
For further information, please contact:Contacts: Róbert Róbertsson, CFO of Kaldvik AS: +354 843 0086 (mobile)
About Kaldvik ASKaldvik AS is one of the leading salmon farmers in Iceland. Kaldvik AS has a well-developed and fully integrated value-chain controlling all steps from hatchery to sales, enabling the group to provide its customer with a sustainable premium product. Kaldvik AS is headquartered in Iceland.
This information...
Dassault Aviation: Total number of shares and voting rights – 31 12 24
Written by Customer Service on . Posted in Public Companies.
DASSAULT AVIATION
French corporation (société anonyme) with a share capital of 62,876,448.80 euros Headquarters: 9, Rond-Point des Champs-Élysées – Marcel Dassault 75008 PARIS 712 042 456 RCS Paris
Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)DateTotal number of sharesTotal number of voting rights12/31/2024
78,595,561Theoretical voting rights: 130,723,214
Exercisable voting rights: 130,326,152AttachmentTotal number of shares and voting rights – 31 12 24
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
Written by Customer Service on . Posted in Public Companies.
IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $20.0 million, before deducting underwriting fees and other estimated offering expenses payable by the Company. The offering closed on January 7, 2025.
The offering consisted of 40,000,000 Common Units, each consisting of (i) one (1) share of Common Stock, (ii) one (1) Series A Registered Common Warrant to purchase one (1) share of Common Stock per warrant at an exercise price of $0.625 (the “Series A Warrants”) and (iii) one (1) Series B Registered Common Warrant...
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
Written by Customer Service on . Posted in Public Companies.
Successfully dosed 6 patients in safety run-in segment, now accelerating enrollment
Positive data from first four patients announced December 2024
NXC-201 is the only one-time CAR-T therapy in development for AL Amyloidosis
Next program update Q1 2025
AL Amyloidosis is a life-threatening disorder of plasma cells in the bone marrow affecting ~33,000 patients in the U.S.LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated diseases, today announced successful completion of the six-patient Phase 1b safety run-in segment in the U.S. NEXICART-2 study of NXC-201, an investigational CAR-T therapy, in patients relapsed/refractory (R/R) AL Amyloidosis....
The Days of Trend-Chasing Are Over: New Research from Sprout Social Reveals a Third of Consumers Think Jumping on Viral Trends is “Embarrassing” for Brands
Written by Customer Service on . Posted in Public Companies.
The 2025 Sprout Social Index reveals what people now expect from brands on social media, the stakes of getting it wrong, and what marketers should do differently in the new year
CHICAGO , Jan. 07, 2025 (GLOBE NEWSWIRE) — According to The 2025 Sprout Social Index™ Edition XX released today, social media has become the #1 source for keeping up with trends and cultural moments, ranking ahead of TV, family and friends, and every other digital channel. While this shift gives culturally aware brands a greater opportunity to land in people’s feeds, it also means attention is harder than ever to earn, especially in an increasingly saturated social landscape. To avoid getting lost in the noise, brands must move beyond surface-level trend-chasing and instead provide original, human-centric content and personalized, 1:1 engagements—...
XWELL Announces Senior Leadership Appointments and Changes
Written by Customer Service on . Posted in Public Companies.
Ian Brown Appointed XWELL’s CFO Succeeding Suzanne Scrabis
Peter Vermeulen Joins XWELL as its New Head of Human Resources
Mike Heronime Joins XWELL as its New Marketing Director
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced new senior leadership appointments to support the Company’s strategic growth and business objectives. Ian Brown joined the Company as its new Chief Financial Officer on January 6, 2025, succeeding Suzanne Scrabis, whose separation is effective as of January 8, 2025. Mr. Brown has deep financial expertise and a proven track record in operational excellence, business operations and mergers and acquisitions.
XWELL announced that in connection with Mr. Brown’s employment...
Inspirato Announces Plans to Expand Its Curated Portfolio of Residences and Destinations
Written by Customer Service on . Posted in Public Companies.
The luxury travel club targets new destinations across Europe, Caribbean, California, U.S. East Coast, Mountain and Ski destinations and more
DENVER, Jan. 07, 2025 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the premier members-only luxury vacation club is excited to share its plans for significant expansion in 2025 and beyond. This initiative intends to add new homes in some of the world’s most sought-after destinations while enhancing its portfolio in key existing markets to provide members with a truly unparalleled travel experience.
New & Expanded DestinationsEurope: Amalfi Coast, Bodrum, Capri, Côte d’Azur, Istanbul, Mallorca, Mykonos, Paris, Podgorica, Sardinia
Caribbean: St. Barts, St. John, St. Thomas, Turks & Caicos
California: Beverly Hills, La Jolla, Malibu,...